Field trials for the DSM-5 fail to explicitly compare new proposed diagnostic criteria with those in the DSM-IV, a step that would be too costly and time-consuming according to vice-chair of the task force Darrel Regier. “You just don’t do science that way,” says Allen Frances, chairman of the DSM-IV task force and a critic of the DSM-5.
Newsflash from APA Meeting: DSM-5 Has Flunked Its Reliability Tests (Huffington Post)
Updates to Psychiatric Guide Spur Controversy (Washington Post)
First DSM-5 Field Trials Generate Mixed Results (Medscape Today)
Psychiatry Manual Drafters Back Down on Diagnoses (New York Times)
Related “In the News” Items:
APA Proposes Alternative to Juvenile Bipolar
Incoming APA President Emphasizes “Positive Psychiatry”
Weak Field Trials Scuttle DSM-5 Diagnoses
DSM-5 Retreats from Some Controversial Diagnoses
Ethics Complaints Over DSM Filed With the APA
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.